Pharmaceutical Technology

SEPTEMBER 15, 2022

The information contained within the download document is useful for pharmaceutical executives, drug development officers, product marketing managers, marketing executives, medical representatives, senior procurement executives, pharma packaging development specialists, and any other individual involved in pharmaceutical commercial packaging.

Packaging 130

Packaging Packaging Marketing Containment 130

Pharma Packaging Solutions

DECEMBER 17, 2020

It is obvious that if you do not make the product in America, you certainly do not need the package. Offshoring increased sales and profits but over time the ability to respond to market conditions, innovations, and controls on the supply chain were sacrificed. The post Made In America appeared first on Pharma Packaging Solutions.

Packaging 52

Packaging Packaging Contract Packaging Manufacturing 52

Roots Analysis

APRIL 20, 2022

In addition, over the next five years, the global pharmaceutical market is projected to grow at a CAGR of 4.7%, with global drug sales anticipated to raise revenues worth USD 1.5 Further, studies indicate that more than 100,000 tons of pharmaceutical products are consumed globally per year. trillion in 2023.

Packaging 52

Packaging Packaging Marketing Production 52

Pharma Packaging Solutions

JULY 17, 2023

It Single-Dose Packaging: The CFR states that single-dose biological products are not required to be packaged one per carton. Final Containers: Biologics prepared or imported in a carton or other container must not be removed from the container for sale unless each individual product is affixed with the appropriate labeling.

Packaging 52

Packaging Packaging Containment Regulation 52